Arshad Ahmed
Arshad Ahmed is an executive and a strategy consultant with over 25 years of experience in driving innovation and M&A activity in Life sciences. He currently serves as Vice President of Business Development at 1Cell.Ai, where he drives sales and BD activities into the pharma/biopharma vertical to advance Cell Biopsy powered by OncoIncytes. This next-generation platform integrates single-cell DNA, RNA, and protein profiling from blood to enable real-time insights into tumor biology for drug development and biomarker discovery.
Previously Arshad has held senior executive level positions at several multinationals including Danaher where he was the Vice President of Strategy and Business Development where his team developed the strategy and business case for transformative acquisitions such as Pall Corporation. Arshad was the founding Partner of Scientia Advisors management consulting (now Precision Medicine Group) focused on life sciences and healthcare strategy. Over the years, he has advised large companies in Pharmaceuticals, Life Sciences Tools, Diagnostics, Medtech, and Digital Health Informatics sectors.
Arshad holds a BS in Electrical Engineering and Computer Science from the University of Illinois and an MBA in Finance and Business Strategy from the University of Chicago.